Children in developing countries are continually exposed to enteric pathogens \[[@JIV772C1]--[@JIV772C4]\]. This results in high rates of morbidity and mortality, especially in infants \[[@JIV772C5]\]. The outcome of an *Entamoeba histolytica* exposure can be diarrhea, dysentery, or amebic liver abscess, with the latter occurring mainly in men \[[@JIV772C6]\]. Disease, however, occurs in a minority of *E. histolytica* infections (approximately 20%) \[[@JIV772C6]\]. While both host and parasite factors contribute to outcome, they do not entirely explain susceptibility \[[@JIV772C7]--[@JIV772C9]\].

A prospective longitudinal study of enteric pathogens in a slum community in Dhaka, Bangladesh, has provided a rich data set to identify parameters important for protection and disease. It has been previously shown that children in this study cohort who are malnourished at birth are more susceptible to amebiasis and in general experience more-severe diarrhea \[[@JIV772C2]\]. There is evidence in support of both passive and active acquired immunity. Infants with mothers with high levels of breast milk anti-galactose/N-acetylgalactosamine (Gal/GalNAc) lectin immunoglobulin A (IgA) had fewer *E. histolytica* infections, and children with fecal IgA anti-Gal/GalNAc lectin IgA also had a lower incidence of new infection \[[@JIV772C10], [@JIV772C11]\].

Weaning and the introduction of supplementary food into the diet is known to trigger changes in the bacterial composition of the microbiome that include increases in Prevotellaceae and *Bacteroides* species \[[@JIV772C12], [@JIV772C13]\]. The first 2 years of life in general is a period of rapid immune and microbiome maturation, which, in this population, may be disrupted by malnutrition and environmental insult \[[@JIV772C13]--[@JIV772C15]\].

Here we describe the natural history of amebiasis in the first 2 years of life in infants from an urban slum in Dhaka. The cumulative incidence of amebic infection and diarrhea, the association of protection with anti-Gal/GalNAc lectin IgA, the impact of parasite burden on symptoms, and potential role of *Prevotella copri* in *E. histolytica* diarrhea are described.

MATERIALS AND METHODS {#s2}
=====================

Study Area and Population {#s2a}
-------------------------

Details of the study methods have been described in depth elsewhere \[[@JIV772C3], [@JIV772C10], [@JIV772C16]\]. In brief, 392 children born into an urban slum of Dhaka were enrolled in the first week after birth into a community-based prospective cohort study of enteric infections. Socioeconomic information about the study households was collected upon enrollment, using a structured questionnaire (Table [1](#JIV772TB1){ref-type="table"}). In this article, we report the data on the children followed through the second year of life, in the study period ending 5 May 2012. Table 1.Characteristics of the Study Population, by *Entamoeba histolytica* Infection Status During the First 2 Years of LifeCharacteristicInfected (n = 307)Uninfected (n = 85)*P* ValueMale sex, no. (%)169 (55.0)48 (56.5).82Family income, BDT6860.5 ± 3089.86534.2 ± 2900.4.38Maternal education duration, y^a^3.7 ± 3.63.9 ± 3.5.80Family size, no.5.4 ± 2.25.4 ± 2.3.96Maternal BMI21.4 ± 3.321.1 ± 3.1.37Exclusive breast feeding, d118.4 ± 67.4129.6 ± 65.2.17LAZ, by age At birth−0.97 ± 1.17−0.92 ± 1.10.73 1 y−1.80 ± 1.44−1.95 ± 1.51.39 2 y−2.43 ± 1.71−2.53 ± 1.65.63[^3][^4][^5]

Child development was followed by length-for-age *z* (LAZ) score measurements every quarter. Field workers visited the child\'s household twice weekly to record any diarrheal event; 1 stool sample was collected at the time of the diarrheal event, and 1 was collected during monthly surveillance.

Clinical Definitions {#s2b}
--------------------

Diarrhea was defined as having ≥3 unformed or abnormal stools (as defined by the mother) in a 24-hour period \[[@JIV772C2]\]. A diarrheal episode was defined as being separated from another episode by at least 3 diarrhea-free days. However, if *E. histolytica* was detected in samples \<60 days apart, they were counted as part of a single *E. histolytica* infection \[[@JIV772C17]\]. Because infection with multiple enteric pathogens was common in our study population, an episode of diarrhea was only counted as being caused by *E. histolytica* if infection was coincident with symptoms and if the parasite had not been detected in the previous monthly surveillance stool sample \[[@JIV772C3]\].

Sampling and Specimen Testing {#s2c}
-----------------------------

The diarrheal and monthly surveillance stool specimens were tested for *E. histolytica* by use of the stools-specific Tri-Combo enzyme-linked immunosorbent assay (ELISA; TechLab, Blacksburg, Virginia) and an in-house ELISA for anti-*E. histolytica* IgA anti-Gal/GalNAc lectin (TechLab) \[[@JIV772C17], [@JIV772C18]\]. Positive stool samples were retested with the *E. histolytica* species-specific *E. histolytica* II enzyme linked immunosorbent assay (ELISA; TechLab) \[[@JIV772C19]\]. Samples were also tested by a species-specific quantitative polymerase chain reaction (qPCR) assay on DNA extracted from feces ([Supplementary Table A1](http://jid.oxfordjournals.org/lookup/suppl/doi:10.1093/infdis/jiv772/-/DC1)) \[[@JIV772C20]--[@JIV772C22]\]. As previously reported, qPCR assay results with a quantification cycle (Cq) of \>35 were negative for antigen in fecal specimens \[[@JIV772C3]\]. Anti-*E. histolytica* IgA against the CRD region of the Gal/GalNAc lectin (Eh-IgA) was measured in both diarrheal and surveillance stool specimens by use of an in-house ELISA assay as previously described, children were regarded as having fecal specimens positive for anti-*E. histolytica* IgA against the CRD region of the Gal/GalNAc lectin when the A~450~ value was ≥0.2 \[[@JIV772C23]\].

*P. copri* and *Bacteroides thetaiotaomicron* were detected using qPCR primers described by Scher et al, SensiFAST qPCR mix (Bioline, Taunton, Massachusetts), and the CFX96 PCR machine (Bio-Rad, Hercules, California; [Supplementary Table A1](http://jid.oxfordjournals.org/lookup/suppl/doi:10.1093/infdis/jiv772/-/DC1)) \[[@JIV772C24]\]. A qPCR assay based on the primers described by Barman et al was used to detect 16S genes of Enterobacteriaceae, and a standard curve, using DNA extracted from known amounts of *Escherichia coli* (ATCC 25922), was used to determine the equivalent concentration of bacteria ([Supplementary Table A1](http://jid.oxfordjournals.org/lookup/suppl/doi:10.1093/infdis/jiv772/-/DC1)) \[[@JIV772C15]\]. Fecal DNA was used to confirm that the amplification efficiency of Enterobacteriaceae*, P. copri*, and *B. thetaiotaomicron* qPCR assays were comparable. The common reaction conditions consisted of a 3-minute hot start at 95°C, followed by DNA amplification for 40 cycles (a denaturation step at 95°C for 15 seconds followed by an annealing/extension step at 60°C for 15 seconds and plate reading). Melting curve analysis was then used to check that the designated target was amplified. To confirm *P. copri* assay specificity, the amplicon from selected clinical samples was sequenced and compared to that from cultured *P. copri* (CB7, DSMZ; a kind gift from D. Littman; [Supplementary Figure A1](http://jid.oxfordjournals.org/lookup/suppl/doi:10.1093/infdis/jiv772/-/DC1)).

Analysis of Samples Positive for *Entamoeba* Species by qPCR {#s2d}
------------------------------------------------------------

Samples positive by microscopy for *Entamoeba* species but negative by qPCR assays for *E. histolytica*, *Entamoeba dispar*, and *Entamoeba moshkovskii* were analyzed using a modification of the broad range amplification protocol previously described ([Supplementary Table A1](http://jid.oxfordjournals.org/lookup/suppl/doi:10.1093/infdis/jiv772/-/DC1)) \[[@JIV772C25], [@JIV772C26]\]. To adapt the earlier approach to be compatible with results of MiSeq (Illumina, San Diego, California) 150--base pair paired end sequencing (150 cycles), the previously described 432--base pair 18S ribosomal DNA (rDNA) region of the *Entamoeba* genus was amplified in 2 sections, using the primers in ([Supplementary Table A1](http://jid.oxfordjournals.org/lookup/suppl/doi:10.1093/infdis/jiv772/-/DC1)) \[[@JIV772C25], [@JIV772C26]\]. The primers also included Illumina adaptors to permit the preparation of multiplex next-generation sequencing libraries as used in previously described protocols \[[@JIV772C8], [@JIV772C27], [@JIV772C28]\]. No new *E. histolytica--*positive samples were identified in the sample subset, verifying the utility of the *E. histolytica*--specific qPCR assay used in this study \[[@JIV772C20]\]. To expand the characterization of *Entamoeba* strains beyond what has been previously published, a second set of broad range primers was used to amplify the conserved transmembrane sequences of the *E. histolytica* heavy subunit of the Gal/GalNAc lectin *hgl* gene ([Supplementary Figure A2*A*](http://jid.oxfordjournals.org/lookup/suppl/doi:10.1093/infdis/jiv772/-/DC1)). The *hgl* genes of *E. histolytica* are a 4-member gene family and were not as highly amplified as the 18S *Entamoeba* target, which is contained within multicopy rDNA episomes \[[@JIV772C29], [@JIV772C30]\]. Therefore, a nested priming strategy was used that involved an initial amplification with the E_GALNAC primers and a second amplification with the internal E_illumina_n\_GalNAc primer set ([Supplementary Table A1](http://jid.oxfordjournals.org/lookup/suppl/doi:10.1093/infdis/jiv772/-/DC1)). Sequence reads were assembled de novo, using Geneious 7 software (Biomatters, Auckland, New Zealand), and aligned with the *E. histolytica* rDNA and Gal/GalNAc lectin sequences, using ClustalW and Mega 6 software ([Supplementary Figure A2*C*](http://jid.oxfordjournals.org/lookup/suppl/doi:10.1093/infdis/jiv772/-/DC1)) \[[@JIV772C31], [@JIV772C32]\]. The *hgl* sequences of *Entamoeba bangladeshi* were confirmed by amplification with the primers described in [Supplementary Table A1](http://jid.oxfordjournals.org/lookup/suppl/doi:10.1093/infdis/jiv772/-/DC1) and Sanger sequencing.

*E. bangladeshi* Surveillance {#s2e}
-----------------------------

A qPCR assay was designed specific for *E. bangladeshi*, using the primers described in [Supplementary Table A1](http://jid.oxfordjournals.org/lookup/suppl/doi:10.1093/infdis/jiv772/-/DC1) and the SensiFAST SYBR PCR mix ([Supplementary Figure A2*B*](http://jid.oxfordjournals.org/lookup/suppl/doi:10.1093/infdis/jiv772/-/DC1)) (Bioline, Taunton, Massachusetts). Reaction conditions involved a 3-minute hot start at 95°C, followed by a DNA amplification for 40 cycles, which consisted of a denaturation step at 95°C for 10 seconds followed by an annealing/extension step at 63°C for 15 seconds. The companion *E. histolytica*--specific assay used similar reaction conditions except that the annealing/extension step took place at 70°C; the level of fluorescent double-stranded DNA was measured using a CFX96 machine (Bio-Rad). Melting curve analysis was then used to confirm the amplification of the correct target.

Statistical Methods {#s2f}
-------------------

Demographic information, surveillance data, and clinical and laboratory findings were computed in data files, using Fox-Pro (Microsoft, Redmond, Washington). Double data entry was used for all data sets. Differences in categorical data were tested by the χ^2^ test and the Fisher exact test, and differences in continuous data were tested by either a 2-sample *t* test or a nonparametric test, where applicable, using the Prism program (GraphPad Software, La Jolla, California). The time to the first *E. histolytica*--positive event was analyzed as time-to-event data under the survival analysis framework. The survival probabilities from *E. histolytica* were estimated using the Kaplan--Meier method, and differences in the time to infection were evaluated with the log-rank test.

Ethical Considerations {#s2g}
----------------------

The study was approved by the ethical and research review committees of the International Centre for Diarrhoeal Disease Research, Bangladesh, and the Institutional Review Board of the University of Virginia. Informed written consent was obtained from the parents or guardians for the participation of their child in the study.

RESULTS {#s3}
=======

Study Characteristics {#s3a}
---------------------

Children enrolled in the prospective study came from households where the median income was less than \$100 per month and \<40% of the mothers had formal education. However, almost all households reported the use of safe food-handling practices and had access to municipal water (Table [1](#JIV772TB1){ref-type="table"}) \[[@JIV772C2], [@JIV772C10]\].

*E. histolytica* Infection Was Prevalent in the Study Population {#s3b}
----------------------------------------------------------------

By the end of the second year of life, approximately 80% of infants in the study population had experienced at least 1 *E. histolytica*--positive infection, of which 17.3% were associated with diarrhea (Tables [2](#JIV772TB2){ref-type="table"}--[4](#JIV772TB4){ref-type="table"}). To place this in context, in our cohort there were a record of 951 instances of diarrheal disease (mean no. \[±SD\] per child, 2.93 ± 1.856) in the first year of life and 1688 by the end of the second (4.66 ± 3.124). Diarrheal disease could be attributed to *E. histolytica* in 1 of every 20 cases (47 \[5%\] of cases in the first year and 48 (6.5%) in the second year). Table 2.Characteristics of 307 Children With an Initial *Entamoeba histolytica* InfectionCharacteristicDiarrheaColonization^a^Overall54/307 (17.6)253/307 (82.4)Age at infection, d, median (range)200 (4--701)214 (3--717)*E. histolytica* IgA positive--stool8/54 (14.8)57/253 (22.5)Had second infection Overall30/54 (55.6)132/253 (52.2) Symptomatic, no.523 Asymptomatic (colonization), no.25109[^6][^7][^8] Table 3.Characteristics of 162 Children With a Second *Entamoeba histolytica* InfectionCharacteristicDiarrheaColonization^a^Overall28/162 (17.3)134/162 (82.7)Age at infection, d, median (range)430 (153--718)493 (94--719)*E. histolytica* IgA positive--stool8/28 (28.6)17/134 (12.7)Had third infection Overall11/28 (39.3)43/134 (32.1) Symptomatic, no.18 Asymptomatic (colonization), no.1035[^9][^10][^11] Table 4.Characteristics of 54 Children With a Third *Entamoeba histolytica* InfectionCharacteristicDiarrheaColonization^a^Overall9/54 (16.7)45/54 (83.3)Age at infection, d, median (range)621 (332--720)614 (156--716)*E. histolytica* IgA positive--stool2/9 (22)1/45 (2.2)Had fourth infection Overall3/9 (33.3)10/45 (22.2) Symptomatic, no.12 Asymptomatic (colonization), no.28[^12][^13][^14]

Anti-*E. histolytica* IgA Anti-Gal/GalNAc Lectin Was Associated With Protection From Infection {#s3c}
----------------------------------------------------------------------------------------------

As previously shown, protection from *E. histolytica* in the first year of life was associated with the level of anti-*E. histolytica* IgA Gal/GalNAc lectin in the mother\'s breast milk ([Supplementary Figure A4*A*](http://jid.oxfordjournals.org/lookup/suppl/doi:10.1093/infdis/jiv772/-/DC1)) \[[@JIV772C10]\]. As expected, since exclusive breast-feeding did not take place in the second year of life, breast milk IgA was not associated with protection in infants during year 2 ([Supplementary Figure A4*B*](http://jid.oxfordjournals.org/lookup/suppl/doi:10.1093/infdis/jiv772/-/DC1)). In addition, a significantly longer *E. histolytica*--free period was observed if the child developed fecal anti-*E. histolytica* IgA at the time of the initial *E. histolytica*--positive sample: the median survival interval between the first and second infection in IgA-negative children was 373.3 days, compared with 526 days in IgA-positive children, and the log-rank (Mantel--Cox) test result indicated that the survival curves were significantly different (*P* = .02), with a log-rank hazard ratio of 1.586 (95% confidence interval, 1.078--2.140; Figure [1](#JIV772F1){ref-type="fig"}). We concluded that IgA antibodies against the Gal/GalNAc lectin, both in breast milk from the child\'s mother and from the child\'s gut, were associated with protection of the infant from amebiasis. Figure 1.Children with fecal anti-*Entamoeba histolytica* Gal/GalNAc lectin immunoglobulin A (IgA) had a lower rate of reinfection. The *y*-axis denotes the percentage of children with an *E. histolytica* infection (n = 307), and the *x*-axis denotes the interval between the first and second *E. histolytica* infections. A statistically significant increase in the time to reinfection was observed for children who were fecal IgA anti-lectin positive (red line), compared with those who were negative (black line; *P* = .0175, by the log-rank \[Mantel--Cox\] test). A total 65 children tested positive and 242 tested negative for *E. histolytica* IgA.

A Higher Parasite Burden Was Associated With Diarrhea in the First but Not Second Year of Life {#s3d}
----------------------------------------------------------------------------------------------

It has been hypothesized that symptomatic disease occurs when host defenses are overwhelmed by parasite numbers \[[@JIV772C33]\]. In *E. histolytica* events, this supposition was challenged by studies comparing the parasite load in older children and adults seeking care at the Dhaka Hospital with those in asymptomatic community controls \[[@JIV772C1]\]. In the current study, however, in a subset of the asymptomatic and diarrhea samples from children aged \<1 year, a higher parasite burden was observed in symptomatic cases \[[@JIV772C3]\]. Using the entire data set, we confirmed that, in the first year of life, a statistically significant increase in parasite load occurred in symptomatic cases (Figure [2](#JIV772F2){ref-type="fig"}). However, in the second year of life, our findings were similar to the results from the earlier study: no difference in the parasite burden of symptomatic cases was observed \[[@JIV772C1]\]. This finding remained true even if it was repeated using only the children who experienced their initial *E. histolytica* event in the second year of life. This effect on parasite burden was independent of the number of preceding *E. histolytica* events, as determined by examining the qPCR Cq values ([Supplementary Figure A6](http://jid.oxfordjournals.org/lookup/suppl/doi:10.1093/infdis/jiv772/-/DC1)). These results suggested that parasite load was higher in diarrheal stool specimens in the first but not second year of life. Figure 2.Increased parasite burden with diarrhea in first but not second year of life. The amount of *Entamoeba histolytica* in stool specimens from children who had diarrhea and those who were asymptomatic was determined by quantitative polymerase chain reaction (qPCR). Samples collected from an *E. histolytica*--associated diarrheal sample (DS) or a sample in which *E. histolytica* was detected but colonization was not coincident with disease (COL) during the first infection (*A*) and second infection (*B*). The mean and standard error are shown. The *y*-axis indicates the threshold value of the qPCR assay specific for *E. histolytica*. As the quantification cycle distribution was not Gaussian, Kruskal--Wallis 1-way analysis of variance was used to determine that this data set contained significant differences. The Dunn multiple comparison test was used to determine that the year 1 data were significantly different from each other. \**P* ≤ .05 and \*\**P* ≤ .01.

Insights Into the Natural History of Human *E. bangladeshi* {#s3e}
-----------------------------------------------------------

During the in-depth MiSeq analysis of selected specimens sequences encoding the conserved transmembrane region of the Gal/GalNAc lectin family ([Supplementary Table A1](http://jid.oxfordjournals.org/lookup/suppl/doi:10.1093/infdis/jiv772/-/DC1)), data were obtained from an *E. Bangladeshi*--positive specimen ([Supplementary Figure A1](http://jid.oxfordjournals.org/lookup/suppl/doi:10.1093/infdis/jiv772/-/DC1)). A qPCR survey was conducted of cultured microscopically positive samples that could not be assigned to the common *Entamoeba* species of *E. histolytica*, *E. dispar*, or *E. moshkovskii*. Additional *E. bangladeshi* isolates were identified in 3 diarrheal samples and 8 surveillance samples derived from this study cohort \[[@JIV772C25]\]. Given the small number of *E. bangladeshi*--positive samples, it was not possible to come to any conclusions regarding the propensity of *E. bangladeshi* to cause diarrheal disease.

*E. histolytica* does not appear to confer cross-species protective immunity against *E. moshkovskii* or *E. dispar* colonization \[[@JIV772C34], [@JIV772C35]\]. In our study, we observed an *E. histolytica* colonization event prior to the collection 5 days later of an *E. bangladeshi*--positive sample. While this suggests that no barrier exists between colonization with both these *Entamoeba* species, a detectable anti-*E. histolytica* IgA response was not detected, suggesting that a robust mucosal *E. histolytica* immune defense was not mounted.

Environmental Factors Associated With Diarrhea Due to *E. histolytica* {#s3f}
----------------------------------------------------------------------

One factor linked to *E. histolytica--*induced diarrhea in amebiasis is inflammation \[[@JIV772C36]\]. In regions where diarrheal disease is endemic, environmental enteropathy (blunted small-intestinal villi with lamina propria inflammation) is known to occur \[[@JIV772C37]\]. Cases of reported diarrhea from any cause in the cohort were examined to determine whether the number of days of diarrheal illness predicted whether a child experienced overt diarrheal disease or asymptomatic colonization upon an *E. histolytica* event: this was not significantly different in children aged 1--2 years (mean duration \[±SD\], 8.73 ± 6.2 days vs 7.18 ± 5.74 days \[*P* = .1245\]; [Supplementary Figure A7](http://jid.oxfordjournals.org/lookup/suppl/doi:10.1093/infdis/jiv772/-/DC1)).

*P. copri* was associated with plant fiber consumption in humans \[[@JIV772C38]\], associated with colonic inflammation in mouse models \[[@JIV772C24]\], and found in *E. histolytica*--positive fecal samples (C. A. Gilchrist, unpublished observation). We therefore hypothesized that *E. histolytica* diarrhea would be more common in children with high *P. copri* levels. qPCR was used to examine the incidence of *P. copri* infection in symptomatic and asymptomatic children colonized with *E. histolytica* and Enterobacteriaceae rDNA used as an internal reference ([Supplementary Figure A7](http://jid.oxfordjournals.org/lookup/suppl/doi:10.1093/infdis/jiv772/-/DC1)) \[[@JIV772C15]\]. The *P. copri* level (normalized to Enterobacteriaceae values) was significantly increased in diarrhea, compared with asymptomatic infection (*P* = .0095, by the Mann--Whitney test; [Supplementary Figure A8](http://jid.oxfordjournals.org/lookup/suppl/doi:10.1093/infdis/jiv772/-/DC1)), in children between the ages of 600--800 days. An additional 18 samples from another cohort combined with 26 samples from the study cohort children to yield 44 samples (*P* = .0079, by the Mann--Whitney test; Figure [3](#JIV772F3){ref-type="fig"}). This larger data set allowed the effect of age to be scrutinized in conjunction with child symptoms and *P. copri* levels. As expected, in the regression analysis, a significant association with both age and child symptoms (model *P* = .001; *R*^2^ = 0.276) was observed with an estimated mean age effect (±SD) of 1.002 ± 0.431 per month (*P* = .025), indicating that each month increment in age was associated with a 1.002 increase in log *P. copri* levels \[[@JIV772C12], [@JIV772C13]\]. The *P. copri* levels, however, remained significantly lower in asymptomatic children, compared with those with diarrhea, even when age was taken into consideration (estimated mean effect \[±SD\], −5.220 ± 1.392; *P* \< .001). Figure 3.Expansion of *Prevotella copri* was associated with diarrhea due to *Entamoeba histolytica* in children from 600 to 800 days of age. Samples collected between 600 and 800 days of age from an *E. histolytica*--associated diarrheal sample (DS) or a sample in which *E. histolytica* was detected but colonization was not coincident with disease (COL) were compared after normalization to Enterobacteriaceae levels. The *y*-axis denotes the *P. copri* qPCR signal normalized to the Enterobacteriaceae burden, as determined by 16S bacteria ribosomal DNA load (log), and the *x*-axis denotes the specimen type. \*\**P* ≤ .01.

Adults with new-onset untreated rheumatoid arthritis had an expansion of *P. copri* at the expense of a more beneficial member of the *Bacteroides* family, *B. thetaiotaomicron* \[[@JIV772C24]\]. We therefore examined the level of *B. thetaiotaomicron* in these children, but in contrast to the findings of Scher et al, *Bacteroides* levels did not significantly change (data not shown).

DISCUSSION {#s4}
==========

This study represents the first prospective longitudinal of *E. histolytica* infection from birth to 2 years of life. Infection occurred in 80% of the children from the Mirpur slum in Dhaka, with 17% of infections resulting in diarrhea. The most intriguing finding was the association between parasite burden and symptomatic amebiasis in the first year of life and in the second with increased levels the level of a pathobiont, *P. copri*. We had suspected that intestinal dysbiosis and the domination of the gut environment by a pathobiont could affect the phenotype of an *E. histolytica* infection*,* as the children in the study cohort had had intense exposure to enteric infections \[[@JIV772C3]\]. In the second year of life, when the association of *P. copri* with *E. histolytica* diarrhea was observed, only 8.4% of children (33 of 392) had not experienced diarrhea. In a study examining the potential role of the microbiome in older *E. histolytica*--positive patients, the *Bacteroides* species were in general downregulated \[[@JIV772C39]\]. We did not see a significant change in *B. thetaiotaomicron* levels in our population, but any effect may have been masked by the age of our study participants, as an increase in *Bacteroides* numbers occurs during weaning \[[@JIV772C12]\].

Environmental enteropathy is a condition caused by repeated diarrheal events and is often associated with an unfavorable outcome in enteric disease--associated infections \[[@JIV772C40]\]. Because of the association of *P. copri* with systemic gut inflammation in patients and in animal models \[[@JIV772C24]\], this work suggests that *P. copri*, already associated with excessive immune activation, may tip the balance to the development of amebic diarrhea upon *E. histolytica* infection and could be linked, at least in our population, with the syndrome of environmental enteropathy. Combined with recent work showing the importance of the microbiota in controlling susceptibility in the mouse model of amebiasis \[[@JIV772C41]\], the work in humans therefore provides insights into the factors that may control virulence expression \[[@JIV772C40]\].

Studies are needed not only to confirm the link between *P. copri* and amebiasis in human populations but also to investigate the interplay between this bacterium and host inflammation, as well as the role of other members of the gut microflora. In this population, therapies aimed at controlling the expansion of pathobionts may be particularly useful in protecting children from diarrheal disease \[[@JIV772C42]\]. A deeper analysis of the microbiome of these children may allow identification of additional potential deleterious or protective microbes, and future investigations are planned in this regard.

Fecal anti-*E. histolytica* IgA against the CRD region of the Gal/GalNAc lectin was associated with protection however this natural response was insufficient to ameliorate the burden of disease in this age group. There is a need to develop a vaccine against *E. histolytica* that can prevent disease and provide strong and long lasting protection.

Additional studies are also still needed to understand the virulence determinants of the *Entamoeba* species that infect humans. A key component of *E. histolytica* virulence is the Gal/GalNAc lectin, the subunits of which are encoded by a family of genes \[[@JIV772C43]\]. The genome of *E. bangladeshi* also appeared to encode a Gal/GalNAc lectin gene family ([Supplementary Figure A2*C*](http://jid.oxfordjournals.org/lookup/suppl/doi:10.1093/infdis/jiv772/-/DC1)), but the absence of cross-species immunity or the cross-reaction with *E. histolytica* Gal/GalNAc lectin--based immunodiagnostics used in this study suggest that the extracellular domain of the encoded proteins, like those of *E. dispar*, may be dissimilar \[[@JIV772C44]\]. Specific tools therefore will be needed to determine the true prevalence of this organism. This work indicated both that this protozoan organism was circulating within the Bangladesh community and that *E. bangladeshi* could be associated with diarrhea that was occurring at the time of isolation in 3 of the 11 *E. bangladeshi*--positive infants.

In summary, this work suggests that, in addition to the impact of host and parasite genetics in providing protection in amebiasis, the commensal microbiota and the development of protective immunity in regions of endemicity are important protective factors that should be examined to fully understand the risk of contracting symptomatic disease \[[@JIV772C7]--[@JIV772C9], [@JIV772C17]\]. In this study, severity of amebic colitis was influenced by different factors in the gut environment, depending on child age. Early in life, prenatal and perinatal factors, such as birth LAZ score and maternal breast milk IgA antibody level, were associated with *E. histolytica* infection incidence. However, important as these factors were in year 1 of life, they no longer played a significant role in older children. Instead, in children aged 1--2 years, a strong link was observed between an expansion of *P. copri* and diarrheal disease, suggesting that, in this age group, symptomatic outcome of *E. histolytica* is influenced by the microbiome and the inflammatory state of the gut.

Supplementary Data {#s5}
==================

[Supplementary materials](http://jid.oxfordjournals.org/lookup/suppl/doi:10.1093/infdis/jiv772/-/DC1) are available at <http://jid.oxfordjournals.org>. Consisting of data provided by the author to benefit the reader, the posted materials are not copyedited and are the sole responsibility of the author, so questions or comments should be addressed to the author.
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